Research shows promise for CBD in paediatric autism

Research shows promise for CBD in paediatric autism
Cannabis Health News

New research has found that a cannabis-based medicinal product could be an effective therapeutic alternative for children with autism spectrum disorder (ASD). The Phase I/II trial was conducted at the Monash Children’s Hospital in Melbourne and evaluated the efficacy of a full-spectrum medicinal cannabis product – with less than 0.3 per cent THC – produced by Neurotech International. The study adds to previous research that suggests CBD could be used for managing the signs and symptoms of autism. Initial breakthrough results, announced by the company, have shown that 93 per cent of participants had “notable improvement”. ASD is defined as persistent deficits in social communication, social interaction and restricted and repetitive patterns of behaviour. An increasing body of research is showing that substances derived from cannabis could improve the quality of life of autistic children without causing serious adverse effects, providing a therapeutic alternative. Results from this latest study indicated that 93 per cent of participants had notable improvements relating to the severity of illness with no serious side effects after 28 days of daily treatment with the product, known as NTI164. Two patients exhibited vast improvement meaning complete or near remission of all symptoms and 10 showed decided improvement or partial remission of symptoms. Due to the positive therapeutic effects of the CBD-based medicine and feedback from parents, the study has been granted approval for the treatment to continue for a further 54 weeks. The findings have not yet been peer-reviewed. “We are extremely pleased with these breakthrough results for NTI164,” Neurotech International’s, chief executive officer, Dr Alexandra Andrews, said. “The fact that 93 per cent of participants have shown notable improvements without any serious side effects is an outstanding outcome. “We are incredibly grateful for the generous participation of patients and their families as well as the team…

Excerpt only …
Source : Research shows promise for CBD in paediatric autism

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.